Literature DB >> 12143364

Effects of chronic epilepsy on intellectual functions.

Hennric Jokeit1, Alois Ebner.   

Abstract

Intractable epilepsy is related to various transient and chronic brain electric and neurochemical disturbances. There is increasing evidence that long-lasting chronic epilepsy may induce secondary neuronal loss and metabolic dysfunctions. Still a matter of controversy is, however, whether cognitive abilities of patients deteriorate with increasing duration of intractable epilepsy. We present results from two independent cross-sectional studies dealing with measures of global cognitive performance in two different ways. The first study investigated in 78 patients with refractory temporal lobe epilepsy (TLE) the influence of duration of epilepsy on the difference between an estimated measure of former or pre-morbid intelligence and the current performance in an intelligence test. The second study aimed at duration of epilepsy-dependent effects on current IQ measures of 209 patients with refractory TLE. Both studies showed that the duration of epilepsy contributes to the explanation of interindividual variability in IQ measures of adult TLE patients to a higher degree than age and age of epilepsy onset. Similar to several studies on hippocampal neuronal density, hippocampal volume, and glucose metabolism, the presented cross-sectional data demonstrate that a duration of chronic epilepsy exceeding two decades is associated with worse cognitive abilities. Consequently, refractory TLE seems to induce a very slow but ongoing cognitive deterioration. It is assumed that epilepsy-related noxious events and agents exhaust the compensatory capacity of brain functions. A high cognitive reserve capacity, however, might delay the onset of deterioration.

Entities:  

Mesh:

Year:  2002        PMID: 12143364     DOI: 10.1016/S0079-6123(02)35042-8

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  29 in total

Review 1.  Magnetoencephalography for pediatric epilepsy: how we do it.

Authors:  E S Schwartz; D J Dlugos; P B Storm; J Dell; R Magee; T P Flynn; D M Zarnow; R A Zimmerman; T P L Roberts
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

2.  Another good reason to consider surgical treatment for epilepsy more often and sooner.

Authors:  Jerome Engel
Journal:  Arch Neurol       Date:  2011-06

3.  Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

Authors:  Jerome Engel; Michael P McDermott; Samuel Wiebe; John T Langfitt; John M Stern; Sandra Dewar; Michael R Sperling; Irenita Gardiner; Giuseppe Erba; Itzhak Fried; Margaret Jacobs; Harry V Vinters; Scott Mintzer; Karl Kieburtz
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

4.  Recurrent seizures induce a reversible impairment in a spatial hidden goal task.

Authors:  Hai Lin; Gregory L Holmes; John L Kubie; Robert U Muller
Journal:  Hippocampus       Date:  2009-09       Impact factor: 3.899

5.  Seizures in the elderly: impact on mental status, mood, and sleep.

Authors:  Sheryl R Haut; Mindy Katz; Jonathan Masur; Richard B Lipton
Journal:  Epilepsy Behav       Date:  2009-02-02       Impact factor: 2.937

Review 6.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

Review 7.  Cognitive and magnetic resonance volumetric abnormalities in new-onset pediatric epilepsy.

Authors:  Bruce P Hermann; Jana Jones; Raj Sheth; Michael Seidenberg
Journal:  Semin Pediatr Neurol       Date:  2007-12       Impact factor: 1.636

8.  Does memantine improve memory in subjects with focal-onset epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial.

Authors:  Beth A Leeman-Markowski; Kimford J Meador; Lauren R Moo; Andrew J Cole; Daniel B Hoch; Eduardo Garcia; Steven C Schachter
Journal:  Epilepsy Behav       Date:  2018-10-27       Impact factor: 2.937

9.  Effect of age on cognitive sequelae following early life seizures in rats.

Authors:  Havisha B Karnam; Qian Zhao; Tatiana Shatskikh; Gregory L Holmes
Journal:  Epilepsy Res       Date:  2009-04-22       Impact factor: 3.045

10.  [Intelligence development in children with early-onset epilepsy with complex partial seizures].

Authors:  W Pott; M Heyken; H Remschmidt
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.